Medically reviewed by Smita Patel, DO Migraine headaches are predominantly classified as either migraine without aura or ...

This is called familial hemiplegic migraine (FHM). Doctors call cases not linked to a family history “sporadic hemiplegic migraine.” Treatment for hemiplegic migraine is similar to other types ...

A person with familial or sporadic hemiplegic migraine (a rare type of migraine) may have the same symptoms as those that occur in migraine with aura as well as motor (muscle) weakness on one side ...

We screened 28 patients who had unilateral weakness with headache; one had familial hemiplegic migraine, two had inconsistent examinations within one session and one failed to complete the interview.

Migraine is a common neurological syndrome that affects approximately 10–20% of the population. The pathophysiology of migraine is unclear. 5-hydroxytriptamine is a key mediator in the ...

A drug called ubrogepant, which is already used to treat migraines, has now been found to reduce the non-headache symptoms that often hit in the hours preceding a migraine itself – making it the ...

Scientists have shown that a drug approved to treat migraine headaches can also alleviate debilitating non-headache symptoms, such as fatigue, brain fog and blinding light sensitivity, that occur ...

The “migraine meal” is a large Coca-Cola and an order of large fries — and many sufferers online can’t get enough of this combo. One viral video — with more than 3.8 million views ...

The neural mechanisms of many symptoms associated with migraine have yet to be elucidated. New research suggests that a non-image-forming retinal pathway and signals from the dura mater contribute ...

If you have ever experienced a migraine, you know it is not just a headache - it is a full-body shutdown. Migraines bring severe, pounding pain in the head, sensitivity to light, nausea, and brain fog ...

Research on vestibular migraine treatment has been largely inconsistent, showing mixed results for a range of drugs, says Jeffrey Staab at the Mayo Clinic in Rochester, Minnesota. A few newer ...

Cohort enrollment across 61 centers in 12 countries included 353 adults aged 18–70 years with a diagnosis of episodic or chronic migraine and major depressive disorder. Participants were ...